Deltex Medical Group (LSE:DEMG) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group 3-Year EBITDA Growth Rate?

Deltex Medical Group's EBITDA per Share for the six months ended in Dec. 2023 was £0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Deltex Medical Group was 47.70% per year. The lowest was -13.00% per year. And the median was 15.65% per year.

Competitive Comparison of Deltex Medical Group's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Deltex Medical Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deltex Medical Group's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Deltex Medical Group's 3-Year EBITDA Growth Rate falls into.

Deltex Medical Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Deltex Medical Group (LSE:DEMG) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Deltex Medical Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Deltex Medical Group (LSE:DEMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

DTXMF:USA

Address

Terminus Road, Chichester, W Sussex, GBR, PO19 8TX

Website

https://www.deltexmedical.com/

Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (LSE:DEMG) Headlines

No Headlines